Meditor Group LTD Alkermes Plc. Transaction History

Meditor Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 09, 2021	SELL	$18.21 - $23.2 $11 Million - $14 Million	-603,790 Closed	0 $0
Q4 2020 Jan 06, 2021	SELL	$15.39 - $22.1 $2.25 Million - $3.23 Million	-146,210 Reduced 19.49%	603,790 $12 Million
Q2 2020 Jul 14, 2020	SELL	$13.31 - $19.41 $1.52 Million - $2.22 Million	-114,417 Reduced 13.24%	750,000 $14.6 Million
Q1 2020 Apr 30, 2020	SELL	$13.06 - $21.24 $365,457 - $594,358	-27,983 Reduced 3.14%	864,417 $10.1 Million
Q4 2018 Jan 02, 2019	SELL	$27.94 - $44.61 $3.86 Million - $6.17 Million	-138,239 Reduced 13.41%	892,400 $26.3 Million
Q3 2017 Oct 17, 2017	BUY	$49.16 - $54.45 $50.7 Million - $56.1 Million	1,030,639	1,030,639 $52.4 Million

349

182M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.94B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Meditor Group LTD, based on Form 13F filings with the SEC.

Stay updated on Meditor Group LTD with notifications on news.